Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Connecta Therapeutics SLStartup |
Active Organization- |
Inactive Organization Connecta Therapeutics SLStartup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fragile X Syndrome | Preclinical | ES | Connecta Therapeutics SLStartup | 22 Sep 2022 |